Delivery Order SPE2DB20D2002-SPE2DB24FL25P
- Not listed
- This federal contract award, valued at $1,129.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Lantus Solostar 100 unit/mL 3mL, a medication used to treat diabetes. The contract has an ultimate completion date of April 30, 2025 and is a firm fixed-price contract. This award is not associated with a set-aside and appears to be part of a...
- This federal contract award, with a value of $1,384.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lantus Solostar 100 unit/mL 3mL, a medication used for the treatment of diabetes. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
- This federal contract award, valued at $1,098.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lantus Solostar 100 unit/mL 3mL, a diabetes medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00. This IDC enables Amerisourcebergen to supply a wide range of...
- This federal contract award, valued at $1,406.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for DLA Troop Support Medical to procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,557.73, is a delivery order for Lantus Solostar 100 unit/mL 3mL, a specialty medication used for diabetes management. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award, valued at $1,734.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has an ultimate completion date of February 9, 2024, is for the delivery of Lantus Solostar 100 unit/mL 3mL, a medication used to treat diabetes. The contract is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This federal contract award, valued at $3,683.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Lantus Solostar 100 unit/ml 3ml, a diabetes medication, with an ultimate completion date of April 18, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999.00. This IDC, designated as SPE2DX, provides a...
- This federal contract award, valued at $7,427.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lantus Solostar 100 unit/ml 3ml, a prescription medication used to treat diabetes. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00,...
- This federal contract award, valued at $1,022.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Lantus Solostar 100 unit/ml 3ml, a diabetes medication. This is a firm fixed-price delivery order contract with a completion date of May 15, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,187.60 firm fixed-price contract is for the supply of Lantus Solostar 100 unit/mL 3mL, a medication used to treat diabetes. The contract does not have a set-aside designation, indicating open competition. It is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB24FL25PDelivery Order
This federal contract award, valued at $1,396.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract covers the delivery of Lantus Solostar 100 unit/mL 3mL, a specialty medication used to treat diabetes. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular delivery order has a firm fixed-price pricing type and a completion date of February 20, 2024. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 2/16/24 |